$KDK

Cantor Fitzgerald reiterates Kodiak AI stock rating on driverless progress

Cantor Fitzgerald reiterated an Overweight rating and $12.00 price target for Kodiak AI (NASDAQ:KDK), citing progress in autonomous trucking. The stock has fallen 85% year-to-date. Kodiak reported 40,000 cumulative hours of paid driverless operations and plans to begin unsupervised highway service in Q4 2026. Analysts have mixed ratings and price targets for the company.

Original reporting
Published Oct 12, 2026, 12:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 12:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$KDK
Bullish
medium confidence
Mentioned
$KDK
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$KDKBullishLow
01

Why it matters

Analyst rating reiteration could spur short‑term buying, but the company's cash burn and capital raise needs temper upside.

02

Market read

The story is primarily a rating update for a micro‑cap stock, offering limited trading impetus beyond potential short‑term price movement.

03

What to watch

Potential regulatory hurdles and the timeline for unsupervised highway service could delay revenue growth.

Relevance 4/10Novelty 3/10Timing: today

Background

Kodiak AI (NASDAQ:KDK) is a micro‑cap autonomous trucking company reporting driverless mileage and upcoming unsupervised service, while analysts update their price targets.

Company-level read

Ticker impact

$KDKBullishMedium confidence
Context

Cantor Fitzgerald reiterated an Overweight rating and a $12.00 price target for Kodiak AI, noting its driverless truck operations and upcoming unsupervised highway service.

Expected impact

potential upward pressure as investors price in the new target and driverless milestones

Evidence & confidence

The reiteration adds a higher target than current price, but the news is a repeat of analyst coverage rather than a fresh corporate event.

Market effects

Highlights continued investor interest in autonomous trucking and AI-driven logistics.

Limited to U.S. and North American logistics investors.

Modest, as the story pertains to a micro‑cap AI trucking firm.

Counterpoint

The high price target may be overly optimistic given the company's cash burn and need for additional capital.

Key entities

  • Kodiak AI

    Autonomous trucking firm (NASDAQ:KDK).

  • Cantor Fitzgerald

    Investment bank reiterating Overweight rating and $12 target.

Related articles

$KDKMed

This driverless-truck company could be a 'long-term winner' in a market Tesla plans to enter soon

Kodiak AI (KDK) shares rose 5.3% after Oppenheimer initiated coverage with an outperform rating, citing its potential in autonomous trucking. The company reported Q2 revenue of $3.5M, a net loss of $37.7M, and 40,000 paid driverless hours. Analysts see 178% upside, but note financing risks. Tesla (TSLA) also plans to enter the market with its Semi truck, targeting autonomous capabilities by 2024.

$KDKMed

Kodiak AI, Inc.: Kodiak AI Receives DMV Permit to Test Autonomous Trucks in California

Kodiak AI (Nasdaq: KDK) said it received a California DMV drivered testing permit under the state’s expanded Autonomous Vehicle Tester program. The permit, approved Aug. 13, 2026, allows Kodiak to test heavy-duty autonomous trucks on public roads with a safety driver in the cab. The DMV’s phased approach moves from drivered testing to driver-out testing and deployment.

$KDKMedAI 8/10

Kodiak AI Reports Second Quarter 2026 Results and Advances Toward Long-Haul Driverless Launch

Kodiak AI, Inc. (KDK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Kodiak AI Reports Second Quarter 2026 Results and Advances Toward Long-Haul Driverless Launch • Kodiak deployed seven additional driverless trucks during Q2, bringing the customer-owned fleet to 35 vehicles at quarter-end • Kodiak Driver-powered trucks surpassed 40,000 Cumulative

$ABBVMed

AbbVie to Present Data at the 2026 European Society for Medical

AbbVie (ABBV) will present data on seven oncology assets at the 2026 ESMO Congress, highlighting progress in lung, colorectal, ovarian, prostate, and gastric cancers. Key findings include Temab-A's 30% ORR in CRC and 50% ORR in NSCLC, ABBV-706's 56% ORR in SCLC, and ABBV-969's 90% ctDNA reduction in mCRPC. The company aims to showcase its solid tumor portfolio's potential.

$RIOMed

PRE-MARKET AUSTRALIAN STOCK NEWS: Woodside Energy (WDS AT) suspended pre-commissioning at its Scarborough gas project after Greenpeace activists boarded the offshore platform

Woodside Energy (WDS AT) halted pre-commissioning at its Scarborough gas project due to Greenpeace activists. Cleanaway Waste Management (CWY AT) will update on EQT's AUD 3.13/shr proposal. Rio Tinto (RIO AT) plans to expand commodity trading. South32 (S32 AT) shareholders approved asset sale to Alcoa (AA).